Correlation Between Exhaled Propofol Concentration With Plasma Concentration in Children
Propofol in Expiratory Air, a Comparison With Plasma Propofol, BIS Value and Calculated Plasma Concentration During General Anesthesia in Children
1 other identifier
interventional
32
1 country
1
Brief Summary
Children due for elective eye surgery in propofol based anesthesia will be kept at steady state propofol infusion for maintenance, ventilation via endotracheal tube. Exhaled propofol will be measured continously by Edmon (R) (BBraun) monitor and compared with arterial plasma samples of propofol, drawn 3-5 times during the procedure.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 30, 2019
CompletedStudy Start
First participant enrolled
October 30, 2019
CompletedFirst Posted
Study publicly available on registry
November 4, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2021
CompletedMarch 9, 2026
March 1, 2026
8 months
October 30, 2019
March 5, 2026
Conditions
Outcome Measures
Primary Outcomes (2)
Propofol plasma concentration versus simultaneous exhaled concentration
repeated blood samples of propofol concentration
5 hours
Realtionship between Paedfusor-estimated propofol concentration and measured concentration in plasma samples
During general anaesthesia
Secondary Outcomes (1)
Propofol exhaled correlation versus Bispectral Index value (BIS)
5 hours
Study Arms (1)
propofol
EXPERIMENTALpropofol general anesthesia, exhaled measurement of propofol
Interventions
Eligibility Criteria
You may qualify if:
- elective eye surgey
You may not qualify if:
- known propofol hypersensitivity
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Oslo University Hospital
Oslo, 0424, Norway
MeSH Terms
Conditions
Study Officials
- STUDY DIRECTOR
Kristin Thagaard, MD
Oslo University Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor, Consultant
Study Record Dates
First Submitted
October 30, 2019
First Posted
November 4, 2019
Study Start
October 30, 2019
Primary Completion
June 30, 2020
Study Completion
June 30, 2021
Last Updated
March 9, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share